Literature DB >> 16887986

Sialoadhesin promotes the inflammatory response in experimental autoimmune uveoretinitis.

Hui-Rong Jiang1, Lenias Hwenda, Kimmo Makinen, Cornelia Oetke, Paul R Crocker, John V Forrester.   

Abstract

Macrophages are a prominent component of the effector cell compartment in a number of CD4+ T cell-mediated organ-specific autoimmune diseases. In this study, we investigated the role of the sialic acid binding Ig-like lectin sialoadhesin (Sn, Siglec-1) in a model of interphotoreceptor retinal binding protein peptide-induced experimental autoimmune uveoretinitis in mice with targeted deletion of Sn. Our data show that compared with wild-type mice, experimental autoimmune uveoretinitis is reduced in severity in the initial stages in the Sn knockout (KO) mice. In addition, there is a reduction in the proliferative capacity of T cells from the KO mice draining lymph nodes after immunization with interphotoreceptor retinal binding protein peptides, which is manifest some days before disease onset and persists for the duration of disease. Furthermore, activated T cells from the draining lymph nodes of Sn KO mice secrete lower levels of IFN-gamma. The data suggest a role for Sn in "fine tuning" the immune response to autoantigens by modulating T cell priming.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887986     DOI: 10.4049/jimmunol.177.4.2258

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Multifarious roles of sialic acids in immunity.

Authors:  Ajit Varki; Pascal Gagneux
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 5.691

2.  The inhibitory potencies of monoclonal antibodies to the macrophage adhesion molecule sialoadhesin are greatly increased following PEGylation.

Authors:  Julie Ducreux; Rita Vanbever; Paul R Crocker
Journal:  Bioconjug Chem       Date:  2008-09-23       Impact factor: 4.774

3.  Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides.

Authors:  Astrid P Heikema; Mathijs P Bergman; Hannah Richards; Paul R Crocker; Michel Gilbert; Janneke N Samsom; Willem J B van Wamel; Hubert P Endtz; Alex van Belkum
Journal:  Infect Immun       Date:  2010-04-26       Impact factor: 3.441

Review 4.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

5.  Bowman lecture on the role of inflammation in degenerative disease of the eye.

Authors:  J V Forrester
Journal:  Eye (Lond)       Date:  2013-01-04       Impact factor: 3.775

6.  Sialoadhesin ligand expression identifies a subset of CD4+Foxp3- T cells with a distinct activation and glycosylation profile.

Authors:  Dana Kidder; Hannah E Richards; Hermann J Ziltener; Oliver A Garden; Paul R Crocker
Journal:  J Immunol       Date:  2013-02-13       Impact factor: 5.422

7.  Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression.

Authors:  Chuan Wu; Uwe Rauch; Eva Korpos; Jian Song; Karin Loser; Paul R Crocker; Lydia M Sorokin
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

8.  Porcine sialoadhesin: a newly identified xenogeneic innate immune receptor.

Authors:  L G Brock; P L Delputte; J P Waldman; H J Nauwynck; M A Rees
Journal:  Am J Transplant       Date:  2012-09-07       Impact factor: 8.086

Review 9.  Cell transplantation strategies for retinal repair.

Authors:  E L West; R A Pearson; R E MacLaren; J C Sowden; R R Ali
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

10.  Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni.

Authors:  Mariliis Klaas; Cornelia Oetke; Leanne E Lewis; Lars P Erwig; Astrid P Heikema; Alistair Easton; Hugh J Willison; Paul R Crocker
Journal:  J Immunol       Date:  2012-07-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.